This $24,785,826.00 definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to the non-profit Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is to develop innovative and safe multivalent anti-opioid vaccines that protect against heroin and fentanyl. The work will involve activities such as adjuvant screening, immunogen design, and fundamental immune mechanism research to induce protective anti-opioid antibodies. Vaccine candidates will be evaluated in animal models and a lead candidate will advance to early-stage clinical trials. This contract award is not subject to a set-aside and was issued under a Broad Agency Announcement (BAA) solicitation from NIAID.
Generated 9/25/24, 9:33 AM